

Eleuthero, Russian ginseng, devil's shrub, touch-me-not, wild pepper, shigoka, ci wu ja
Eleu-Kokk®
Siberian ginseng is derived from a perennial plant primarily found in Northern Asia. Although it is not a species of ginseng, it is thought to have comparable activities (1). Siberian ginseng, or eleuthero, has been used traditionally as an adaptogen, performance enhancer, and immunostimulant (2). Active components are thought to include several eleutherosides and polysaccharides (3) (4). No large randomized clinical trials have been conducted in humans. However, a small clinical study in patients with knee osteoarthritis found that an herbal mixture containing Siberian ginseng relieved pain and improved physical function (5). Another small study found that Siberian ginseng may have a beneficial effect on bone remodeling in post-menopausal women (6). Siberian ginseng supplementation may also help reduce cholesterol in postmenopausal women (7). In vitro and in vivo studies suggest that Siberian ginseng extracts have a neuroprotective effect (8) and may reduce glucose levels in insulin-deficient animals (9). Eleuthero extract has also been shown to bind to estrogen, progestin, and mineralocorticoid receptors (10), and stimulate T-lymphocyte and natural killer cell production (11). Adverse events include drowsiness, tachycardia, nervousness, and possible hypoglycemia. Siberian ginseng may interact with digoxin (12), insulin and hypoglycemics agents (13).
In vitro studies indicate that eleuthero contains chemicals that bind to estrogen, progestin, mineralocorticoid, and glucocorticoid receptors (10). In macrophages, a Siberian ginseng extract suppressed LPS-induced iNOS expression and thus nitric oxide production by possibly inhibiting nuclear factor-kappa B activity (15) (16) or Akt and JNK signaling (16), and inhibited reactive oxygen species production (17). Siberian ginseng extract also moderately inhibited breast cancer resistance protein (BCRP)-mediated methotrexate transport in BCRP-expressing membrane vesicles (21). Eleutheroside B, eleutheroside E, and isofraxidin — active constituents of Siberian ginseng — showed protective effects against Aβ(25-35)-induced atrophies of axons and dendrites in rat cultured cortical neurons (22). Isofraxidin also inhibited cell invasion and the expression of matrix metalloproteinase-7 by human hepatoma cell lines HuH-7 and Hep G-2, possibly through the inhibition of ERK1/2 phosphorylation (18). In animal studies, eleuthero root bark was shown to exhibit neuroprotective effects against global cerebral ischemia with recovery of spatial memory in rats, possibly through anti-inflammatory mechanisms of inhibition of COX-2 expression, microglia and astrocyte expression (23). Eleutherosides restored behavioral and biochemical alterations in mice with sleep deprivation (24), and alleviated both physical and mental fatigue in mice possibly due to increased fat utilization, delayed accumulation of blood urea nitrogen, and increased lactate dehydrogenase (25). Siberian ginseng extract also decreased cadmium concentration in the blood and liver of mice as well as cadmium-induced mitotic and apoptotic activity of liver cells (26). Siberian ginseng supplementation reduced LDL cholesterol levels and improved LDL/HDL ratios in postmenopausal women (7). Stimulation of helper/inductor T lymphocytes and natural killer cells also occurs by an unknown mechanism (1).
Insulin / hypoglycemics: Theoretical additive hypoglycemic effect (13).
Barbiturates: Eleuthero inhibits metabolism possibly by inhibition of cytochrome p450 2C19 (13).
Digoxin: Elevate serum digoxin levels (12).
Monomycin / Kanamycin: Increases efficacy of these antibiotics due to enhanced T-lymphocyte activity (13).
Siberian ginseng may cause falsely elevated digoxin serum assays (12).
Park SH, et al. Effects of AIF on knee osteoarthritis patients: Double-blind, randomized placebo-controlled study. Korean J Physiol Pharmacol. 2009 Feb;13(1):33-7.
This randomized, double-blind, placebo-controlled study enrolled 57 patients (aged 43-73) who fulfilled the radiographic and American College of Rheumatology criteria for knee osteoarthritis. Patients were randomized into 2 groups and given either 2 capsules twice daily of placebo (n=26) or an herbal formulation (anti-inflammatory factor [AIF]) containing Siberian ginseng extract, Rehmannia glutinosa, and Panax notoginseng (n=31) for 6 weeks. Pain intensity was assessed using the 100 mm visual analogue scale (VAS) at the second, fourth, and sixth weeks and at a 1 week follow-up visit after study end. Patients rated their VAS score as being signficantly reduced at weeks 2 (54.64 + 14.72) and 4 (37.32 + 16.58, p <0.001) after AIF administration. Physical function was evaluated by the K-WOMAC scale, which showed significantly greater (p=0.13) improvement for AIF than for placebo. Decreases in total K-WOMAC score were also more significant (p=0.30) in the AIF than in the placebo group. No serious adverse effects were observed and safety was comparable for both groups. Study investigators concluded that AIF is safe and effective for the symptomatic improvement of pain and physical function in patients with knee osteoarthritis.
Hwang YC, et al. The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. J Bone Miner Metab. 2009;27(5):584-90.
This randomized, open-label, controlled study enrolled 81 post-menopausal Korean women (age<65 years) with ostopenia or osteoporosis. Subjects were randomly assigned to a control (n=40) or treatment group (n=41). Both groups received 500 mg/day calcium and the treatment group also received Siberian ginseng extract. After 6 months the treatment group exhibited a significant change in plasma levels of the bone turnover markers, serium osteocalcin (p=0.041) and CTx, (C terminal telopeptide of type 1 collagen, [p<0.0001]), compared with the control group. However, no significant changes in bone density were observed, possibly due to the short treatment duration.. Siberian ginseng extract was well-tolerated and demonstrated a safety profile comparable to the control group. The authors concluded that Siberian ginseng extract is safe and may beneficially affect bone remodeling in Korean post-menopausal women.
Lee YJ, Chung HY, Kwak HK, Yoon S. The effects of A. senticosus supplementation on serum lipid profiles, biomarkers of oxidative stress, and lymphocyte DNA damage in postmenopausal women. Biochem Biophys Res Commun. Oct 10 2008;375(1):44-8.
To determine the effects of Siberian ginseng supplementation on blood lipid levels and oxidative stress, 40 postmenopausal women were randomly divided into either a control group receiving calcium (500 mg/day) or an experimental group receiving both calcium and A. senticosus capsules (500 mg tid). After 6 months, blood lipid profiles, oxidative stress, and lymphocytic DNA damage was assessed along with hepatoxicity. Serum LDL cholesterol, LDL/HDL ratio, lymphocytic DNA damage, and oxidative stress was significantly reduced in the treatment group while the control group did not experience any changes. Furthermore, no side effects were noted during this study. Further studies are required to determine if A. senticosus supplementation produces long term benefits in other study populations.
Dowling EA, et al. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc. 1996;28:482-9.
A prospective pair evaluation of 6 week supplementation, with either 60 drops of eleuthero extract (eleutheroside B and E) or placebo. Effects on performance, blood chemistry, and personal perception were recorded. Sixteen subjects were paired and analyzed for 6 weeks on therapy and 2 weeks after discontinuation. No significant difference was documented in any of the indices evaluated including heart rate, oxygenation, serum lactate, time to exhaustion, and psychological measurements. No adverse reactions were noted. The authors conclude that the study may have been underpowered or an inadequate dose of eleuthro was studied. Additional studies are required.
Bottom Line: Siberian ginseng does not enhance athletic performance nor treat or prevent cancer.
Scientists are unsure how Siberian ginseng works. Compounds from the plant have been shown to stimulate cells of immune system and protect the nervous system but no large scale clinical trials have been conducted. Other studies have shown that Siberian ginseng supplements brought down LDL cholesterol (bad cholesterol) levels and improved the HDL (good cholesterol) levels in postmenopausal women. Small studies have shown that Siberian ginseng may reduce knee osteoarthritis pain and symptoms and benefit bone metabolism in post-menopausal women. However, more studies are needed.
Improving athletic performance:
The effect of Siberian ginseng (eleuthero extract) on exercise performance was studied in a group of healthy volunteers. For six weeks, 16 volunteers randomly received either 60 drops of eleuthero extract or a placebo liquid. At the end of the study, those subjects taking eleuthero showed no better performance than those taking the placebo, indicating that eleuthero extract is not effective for this use. However, the researchers conducting this study commented that they might not have used a large enough dose or group of volunteers, and therefore additional clinical trials would be useful.